None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects willing to provide signed informed consent prior to the study. 2. Healthy male or female participants aged between 25 and 55 years. 3. Subjects with visible signs of mild to moderate skin aging (e.g., fine lines, wrinkles, dryness). 4. Subjects who committed not to use any other cosmetics during the entire duration of the study. 5. Participants willing to comply with the study protocol and follow-up requirements. 6. Fitzpatrick skin types I–IV.
Exclusion criteria
Exclusion criteria: 1. Subjects with a history of significant dermatological conditions (e.g., eczema, psoriasis) or skin diseases that may interfere with the assessment. 2. History of systemic or cutaneous malignancy or with nevi or cutaneous lesions currently. 3. Patients with known hypersensitivity to ingredients of the trial drug. 4. Patients with history of facial surgery, cosmetic procedures. 5. Participants in any another clinical trial within 30 days prior to the study. 6. Participants in use of any other antiaging skincare treatments within 4 weeks prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •To evaluate the efficacy of the Ashwagandha moisturizing cream in reducing the appearance of fine lines and wrinkles.Timepoint: Anti-aging effect will be assessed on Visit 1(Week 0), Visit 2(Week 4), Visit 3(Week 8), Visit 4(Week 12) and on the day of follow up Visit (Week 16) ? | — |
Secondary
| Measure | Time frame |
|---|---|
| • To evaluate the tolerability and safety profile of the Ashwagandha cream during the study periodTimepoint: Anti-aging effect will be assessed on Visit 1(Week 0), Visit 2(Week 4), Visit 3(Week 8), Visit 4(Week 12) and on the day of follow up Visit (Week 16) ? | — |
Countries
India
Contacts
Pankajakasthuri Ayurveda Medical college and PG centre